Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= CCL4L1 ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: N/A * **<color #00a2e8>Official Name</color>**: N/A * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: N/A * **<color #00a2e8>UniProt</color>**: N/A * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=CCL4L1&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CCL4L1|Open PubMed]] * **<color #00a2e8>OMIM</color>**: N/A == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: N/A * **<color #00a2e8>UniProt Summary</color>**: Monokine with inflammatory and chemokinetic properties. Binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta(3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5- mediated entry of HIV-1 in T-cells. MIP-1-beta(3-69) is also a ligand for CCR1 and CCR2 isoform B. {ECO:0000269|PubMed:10540332, ECO:0000269|PubMed:12070155, ECO:0000269|PubMed:8525373}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |IL8| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |eosinophil chemotaxis| |eosinophil migration| |CCR chemokine receptor binding| |monocyte chemotaxis| |lymphocyte chemotaxis| |mononuclear cell migration| |chemokine activity| |lymphocyte migration| |chemokine-mediated signaling pathway| |neutrophil chemotaxis| |granulocyte chemotaxis| |response to chemokine| |cellular response to chemokine| |neutrophil migration| |granulocyte migration| |myeloid leukocyte migration| |leukocyte chemotaxis| |cellular response to interferon-gamma| |cellular response to interleukin-1| |response to interferon-gamma| |response to interleukin-1| |cell chemotaxis| |positive regulation of ERK1 and ERK2 cascade| |cellular response to tumor necrosis factor| |response to tumor necrosis factor| |regulation of ERK1 and ERK2 cascade| |leukocyte migration| |positive regulation of GTPase activity| |regulation of GTPase activity| |inflammatory response| |positive regulation of MAPK cascade| |chemotaxis| |taxis| |cytokine-mediated signaling pathway| |regulation of MAPK cascade| |innate immune response| |positive regulation of hydrolase activity| |defense response to other organism| |cell migration| |cellular response to cytokine stimulus| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |localization of cell| |cell motility| |response to cytokine| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of protein modification process| |regulation of hydrolase activity| |response to other organism| |response to external biotic stimulus| |locomotion| |G protein-coupled receptor signaling pathway| |response to biotic stimulus| |defense response| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |movement of cell or subcellular component| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |immune response| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp169|BH1 1μM R04 exp169]]|-1.82| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 9573 * **<color #00a2e8>Expression level (log2 read counts)</color>**: N/A <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='NA Expression in NALM6 Cells: N/A'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2025/12/10 20:19by 127.0.0.1